Professor Alastair Noyce

Professional statement

Professor Alastair Noyce is a highly respected consultant neurologist based in London. He is internationally renowned for his expertise in movement disorders, such as Parkinson’s and related disorders, and tremor.

Professor Noyce qualified in medicine with distinction from Barts and the London School of Medicine in 2007. He pursued integrated clinical-academic training through a highly esteemed academic clinical fellowship in neurology, funded by the NIHR and based at University College London and the National Hospital for Neurology and Neurosurgery. He was awarded a clinical research training fellowship from Parkinson’s UK for further research training at University College London between 2012 and 2016. He was awarded a Masters in epidemiology with distinction from the London School of Hygiene and Tropical Medicine in 2016. That same year, he completed his PhD in Neuroscience. Professor Noyce combines his clinical work as a consultant neurologist with his continued cutting-edge research activities and sees private patients at The London Bridge Hospital.

Professor Noyce’s contributions to the field of neurology, in particular to our understanding of Parkinson’s disease and neurodegenerative diseases, their risk factors and early detection, have earned him international acclaim. His extensive research is published in peer reviewed journals, and he regularly shares his expertise at key national and international conferences. Professor Noyce has further clinical and research interests in brain health and in genetic contributions to the risk of neurodegenerative diseases. In recent years, he has worked extensively on understanding the risks posed by recreational nitrous oxide use (laughing gas) and has amassed extensive experience managing young patients who have come to harm. 

Professor Noyce remains active in research which works to advance diagnosis and outcomes for patients with neurodegenerative disease in his role as Lead of the Preventative Neurology Unit at Queen Mary University of London, the Centre for Preventative Detection and Diagnosis and the Wolfson Institute of Population Health. He is also a principal investigator in PREDICT-PD, an innovative study project examining how Parkinson’s can be detected before movement problems develop.